reviewThe Lancet OncologyFeb 16, 2007Closed access

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

The University of Sydney · National Health and Medical Research Council · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

No related works found for this paper.

Funding